185 related articles for article (PubMed ID: 37838774)
61. CAR-NK Cells: From Natural Basis to Design for Kill.
Khawar MB; Sun H
Front Immunol; 2021; 12():707542. PubMed ID: 34970253
[TBL] [Abstract][Full Text] [Related]
62. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
63. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G
Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451
[TBL] [Abstract][Full Text] [Related]
64. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.
O'Connell J; Bennett MW; Nally K; Houston A; O'Sullivan GC; Shanahan F
Ann N Y Acad Sci; 2000 Jun; 910():178-92; discussion 193-5. PubMed ID: 10911913
[TBL] [Abstract][Full Text] [Related]
65. Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.
Randhawa SR; Chahine BG; Lowery-Nordberg M; Cotelingam JD; Casillas AM
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):286-92. PubMed ID: 20408337
[TBL] [Abstract][Full Text] [Related]
66. Ligand-based adoptive T cell targeting CA125 in ovarian cancer.
Zhao H; Wu L; Dai J; Sun K; Zi Z; Guan J; Zhang L
J Transl Med; 2023 Sep; 21(1):596. PubMed ID: 37670338
[TBL] [Abstract][Full Text] [Related]
67. 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation.
Bissonnette RP; Brunner T; Lazarchik SB; Yoo NJ; Boehm MF; Green DR; Heyman RA
Mol Cell Biol; 1995 Oct; 15(10):5576-85. PubMed ID: 7565709
[TBL] [Abstract][Full Text] [Related]
68. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.
Zaks TZ; Chappell DB; Rosenberg SA; Restifo NP
J Immunol; 1999 Mar; 162(6):3273-9. PubMed ID: 10092779
[TBL] [Abstract][Full Text] [Related]
69. Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice.
Li T; Wang J
BMC Cancer; 2020 Jul; 20(1):678. PubMed ID: 32689954
[TBL] [Abstract][Full Text] [Related]
70. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages.
Lu B; Wang L; Medan D; Toledo D; Huang C; Chen F; Shi X; Rojanasakul Y
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C831-8. PubMed ID: 12176740
[TBL] [Abstract][Full Text] [Related]
71. Impact of human CD95 mutations on cell death and autoimmunity: a model.
Seyrek K; Ivanisenko NV; Wohlfromm F; Espe J; Lavrik IN
Trends Immunol; 2022 Jan; 43(1):22-40. PubMed ID: 34872845
[TBL] [Abstract][Full Text] [Related]
72. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
[TBL] [Abstract][Full Text] [Related]
73. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.
Chien MH; Chang WM; Lee WJ; Chang YC; Lai TC; Chan DV; Sharma R; Lin YF; Hsiao M
Mol Cancer Ther; 2017 Jun; 16(6):1102-1113. PubMed ID: 28292939
[TBL] [Abstract][Full Text] [Related]
74. A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome.
Nabhani S; Hönscheid A; Oommen PT; Fleckenstein B; Schaper J; Kuhlen M; Laws HJ; Borkhardt A; Fischer U
Clin Immunol; 2014 Dec; 155(2):231-7. PubMed ID: 25451160
[TBL] [Abstract][Full Text] [Related]
75. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.
Chhipa RR; Bhat MK
J Cell Biochem; 2007 May; 101(1):68-79. PubMed ID: 17340621
[TBL] [Abstract][Full Text] [Related]
76. Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: a role for Fas-FasL.
Collette Y; Benziane A; Razanajaona D; Olive D
Blood; 1998 Aug; 92(4):1350-63. PubMed ID: 9694724
[TBL] [Abstract][Full Text] [Related]
77. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
[TBL] [Abstract][Full Text] [Related]
78. Polymorphisms in FAS and CASP8 genes may contribute to the development of ALPS phenotype: a study in 25 patients with probable ALPS.
Tan Ç; Özgül RK; Çağdaş Ayvaz D; Tezcan İ; Sanal Ö
Turk J Pediatr; 2015; 57(2):141-5. PubMed ID: 26690594
[TBL] [Abstract][Full Text] [Related]
79. Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells.
Tanimoto Y; Kizaki H
J Biochem; 2002 Mar; 131(3):319-26. PubMed ID: 11872160
[TBL] [Abstract][Full Text] [Related]
80. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel.
Symes JC; Kurin M; Fleshner NE; Medin JA
Mol Cancer Ther; 2008 Sep; 7(9):3018-28. PubMed ID: 18790782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
